← Leaderboards
Januario E Castro
University Of California San Diego
$1,312,579
Attributed
$1,312,579
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $337.9K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$712,579 · 5
FDA$600,000 · 1
By mechanism
K08$661,850 · 1
R01$600,000 · 1
M01$50,729 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Thomas J. Kipps$21,947,102
- Robert C Rickert$18,269,835
Others in their field
Top investigators on “Adenoviruses”
- David Heimbrook · Leidos Biomedical Research, Inc.$87,846,116
- Jaap Goudsmit · Beth Israel Deaconess Medical Center$53,211,886
- Larry Arthur$34,591,506
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,036,726
- William George Nelson · Johns Hopkins University$30,145,983
- Daniel F. Hoft · Saint Louis University$29,294,132
Research focus
AdenovirusesLymph NodesClinical TrialsChronic Lymphocytic LeukemiaInstitutionResourcesFundingGrantSafetyResponseInjection Of Therapeutic AgentUnited States National Institutes Of HealthSourceResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseAntigen PresentationPeptide LibraryClone CellsB-LymphocytesB LymphocyteAntigen-Presenting CellsClassChemotherapyClinical Research
Grant awards (12)
Phase I, Open-Label Dose-Escalation$200,000
R01 · FY2010 · FD · contact PI
CLINICAL TRIAL: A PHASE II STUDY OF REPEAT INTRANODAL INJECTIONS OF ADENOVIRUS-C$13,289
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: ADENOVIRUS CD-154 IN SUBJECTS WITH CLL$11,563
M01 · FY2010 · RR · contact PI
Phase I, Open-Label Dose-Escalation$200,000
R01 · FY2009 · FD · contact PI
CLINICAL TRIAL: PK STUDY OF INTRANODAL INJECTION OF ADENOVIRUS-CD154 IN PATIENTS$20,382
M01 · FY2009 · RR · contact PI
Phase I, Open-Label Dose-Escalation$200,000
R01 · FY2008 · FD · contact PI
Immunotherapy for Chronic Lymphocytic Leukemia$132,370
K08 · FY2008 · CA · contact PI
CLINICAL TRIAL: PK STUDY OF INTRANODAL INJECTION OF ADENOVIRUS-CD154 IN PATIENTS$5,495
M01 · FY2008 · RR · contact PI
Immunotherapy for Chronic Lymphocytic Leukemia$132,370
K08 · FY2007 · CA · contact PI
Immunotherapy for Chronic Lymphocytic Leukemia$132,370
K08 · FY2006 · CA · contact PI
Immunotherapy for Chronic Lymphocytic Leukemia$132,370
K08 · FY2005 · CA
Immunotherapy for Chronic Lymphocytic Leukemia$132,370
K08 · FY2004 · CA